Weedmaps, the popular cannabis marketplace platform, is facing a class action lawsuit alleging it misled investors about its performance metrics. The lawsuit follows an SEC settlement where Weedmaps and former executives were fined for inflating user numbers. The company is also battling a stock price decline, risking delisting from NASDAQ.
Faruqi & Faruqi, LLP, a national securities law firm, is investigating potential claims against Lifecore Biomedical, Inc. (LFCR) following a series of financial restatements and delisting warnings. The firm encourages investors who suffered losses exceeding $75,000 to contact them for a discussion of their legal options.
Warrantee Inc. (WRNT) shares plummeted by 29% on Monday after the company received a Nasdaq delisting determination letter. The Nasdaq notified the company on April 15 that its securities would be delisted due to failure to meet the minimum bid price requirement. Warrantee has until April 10, 2024, to rectify the issue and plans to appeal the decision. The company is considering various options, including a reverse stock split. Investors interested in participating in the market for Warrantee can buy shares through a brokerage account, even in fractional amounts, or explore more complex options such as shorting or trading options.
Vaxxinity (NASDAQ: VAXX) announced plans to voluntarily delist its shares from the Nasdaq Exchange. The company will file for delisting on April 29, 2024, expecting its final day of trading on Nasdaq to be May 9, 2024. Vaxxinity received a delisting notice in February requiring it to get its share price above $1 by August 7, 2024. The company chose to delist early to reduce its obligations and save money. Despite the delisting, VAXX stock is expected to continue trading on OTC Markets after May 9.
